Fatty liver disease is one of the fastest-growing health concerns in the U.S., but many people don’t realize they’re at risk until it’s too late.
At Our Lady of the Angels Hospital, we’re stepping up with a new way to take control of liver health. Fibroscan offers a quick, comfortable and noninvasive option for diagnosing and monitoring liver disease. This advanced technology empowers patients and providers with clearer insights into liver health — no biopsy required.
Why Liver Health Matters
Your liver works overtime to keep you healthy, but it’s often taken for granted. Fatty liver disease, linked to factors like obesity, diabetes and alcohol use, can lead to serious complications if left untreated. Unfortunately, it’s often underdiagnosed because early symptoms can be vague or nonexistent.
That’s where Fibroscan comes in. This ultrasound-based technology measures liver stiffness and fat content, helping providers assess damage more easily and accurately.
Who Can Benefit?
Your provider might recommend Fibroscan if you:
- Have risk factors like obesity, diabetes or a history of liver disease
- Experience symptoms such as jaundice (yellowing of the skin or eyes)
- Take certain medications, like Rezdiffra, that can affect liver health
- Need a liver biopsy but prefer a noninvasive option
Putting Patients First
“We are excited to bring Fibroscan technology to our community,” says Brian Galofaro, MD, chief medical officer at Our Lady of the Angels Hospital. “This capability represents a significant advancement in early liver disease detection and management, which is critical for improving long-term patient health.”
Our Lady of the Angels is one of the few facilities in the area offering Fibroscan, demonstrating our dedication to providing the highest standard of care close to home.
Your Next Step
A relationship with a primary care provider can help you navigate liver health with confidence. Whether you’re managing existing concerns or looking to stay proactive, Fibroscan can be part of your care plan.
